Sign in or Register   Sign in or Register
  |  

Mouse Anti-TAB2 Recombinant Antibody (CBYJT-1752) (CBMAB-T0813-YJ)

Provided herein is a Mouse monoclonal antibody, which binds to TAB2 (TGF-Beta Activated Kinase 1/MAP3K7 Binding Protein 2). The antibody can be used for immunoassay techniques, such as ELISA, FC, WB.
See all TAB2 antibodies

Summary

Host Animal
Mouse
Specificity
Human
Clone
CBYJT-1752
Antibody Isotype
IgG1
Application
ELISA, FC, WB

Basic Information

Immunogen
Purified recombinant fragment of human TAB2 expressed in E. coli
Specificity
Human
Antibody Isotype
IgG1
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.

Formulations & Storage [For reference only, actual COA shall prevail!]

Buffer
Ascites
Preservative
0.03% Sodium Azide
Storage
Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

Full Name
TAB2 TGF-Beta Activated Kinase 1/MAP3K7 Binding Protein 2
Introduction
TAB2 is an activator of MAP3K7/TAK1, which is required for for the IL-1 induced activation of nuclear factor kappaB and MAPK8/JNK. TAB2 forms a kinase complex with TRAF6, MAP3K7 and TAB1, and it thus serves as an adaptor that links MAP3K7 and TRAF6. TAB2, along with TAB1 and MAP3K7, also participates in the signal transduction induced by TNFSF11/RANKl through the activation of the receptor activator of NF-kappaB (TNFRSF11A/RANK), which may regulate the development and function of osteoclasts. Studies of the related mouse protein indicate that it functions to protect against liver damage caused by chemical stressors. Mutations in this gene cause congenital heart defects, multiple types, 2 (CHTD2).
Entrez Gene ID
23118
UniProt ID
Q9NYJ8
Alternative Names
TGF-Beta Activated Kinase 1/MAP3K7 Binding Protein 2; Mitogen-Activated Protein Kinase Kinase Kinase 7-Interacting Protein 2; TAK1-Binding Protein 2; MAP3K7IP2; TAB-2; Mitogen-Activated Protein Kinase Kinase Kinase 7 Interacting Protein 2
Function
Adapter required to activate the JNK and NF-kappa-B signaling pathways through the specific recognition of 'Lys-63'-linked polyubiquitin chains by its RanBP2-type zinc finger (NZF) (PubMed:10882101, PubMed:11460167, PubMed:15327770, PubMed:22158122).
Acts as an adapter linking MAP3K7/TAK1 and TRAF6 to 'Lys-63'-linked polyubiquitin chains (PubMed:10882101, PubMed:11460167, PubMed:15327770, PubMed:22158122).
The RanBP2-type zinc finger (NZF) specifically recognizes Lys-63'-linked polyubiquitin chains unanchored or anchored to the substrate proteins such as RIPK1/RIP1: this acts as a scaffold to organize a large signaling complex to promote autophosphorylation of MAP3K7/TAK1, and subsequent activation of I-kappa-B-kinase (IKK) core complex by MAP3K7/TAK1 (PubMed:15327770, PubMed:22158122).
Regulates the IL1-mediated translocation of NCOR1 out of the nucleus (By similarity).
Involved in heart development (PubMed:20493459).
Biological Process
Heart developmentManual Assertion Based On ExperimentIMP:UniProtKB
Negative regulation of autophagyManual Assertion Based On ExperimentTAS:ParkinsonsUK-UCL
Positive regulation of I-kappaB kinase/NF-kappaB signalingManual Assertion Based On ExperimentIDA:UniProtKB
Positive regulation of protein kinase activityManual Assertion Based On ExperimentIDA:UniProtKB
Response to lipopolysaccharideManual Assertion Based On ExperimentIDA:ARUK-UCL
Cellular Location
Membrane
Endosome membrane
Lysosome membrane
Cytoplasm, cytosol
Following IL1 stimulation, translocation occurs from the membrane to cytosol (PubMed:10882101).
Interaction with TRIM38 promotes translocation from cytosol to endosome and lysosome (PubMed:24434549).
Involvement in disease
Congenital heart defects, multiple types, 2 (CHTD2):
A disease characterized by congenital developmental abnormalities involving structures of the heart. CHTD2 patients have left ventricular outflow tract obstruction, subaortic stenosis, residual aortic regurgitation, atrial fibrillation, bicuspid aortic valve and aortic dilation.
PTM
Degraded in a lysosome-dependent manner following interactiuon with TRIM38.
Ubiquitinated; following IL1 stimulation or TRAF6 overexpression. Ubiquitination involves RBCK1 leading to proteasomal degradation.
Phosphorylated.
(Microbial infection) Methylated at Cys-673 by enteropathogenic E.coli protein NleE or S.flexneri protein OspZ: methylation disrupts zinc-binding and ability to bind 'Lys-63'-linked ubiquitin, leading to NF-kappa-B inactivation.
Ask a question We look forward to hearing from you.
0 reviews or Q&As

Purchasing FAQs
Technical FAQs

Loading...
Have you used Mouse Anti-TAB2 Recombinant Antibody (CBYJT-1752)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon $30 eGift Card
Submit a review
Loading...
For research use only. Not intended for any clinical use.

Custom Antibody Labeling

We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).

Online Inquiry

Documents

Contact us

  • Tel: (USA)
  • (UK)
  • Fax:
  • Email:

Submit A Review

Go to
Compare